Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice. [electronic resource]
Producer: 20090223Description: e3548 p. digitalISSN:- 1932-6203
- Adenoviridae -- immunology
- Administration, Intranasal
- Animals
- Antibody Formation -- physiology
- Bronchoalveolar Lavage Fluid -- chemistry
- Drug Delivery Systems -- methods
- Ebola Vaccines -- administration & dosage
- Ebolavirus -- immunology
- Hemorrhagic Fever, Ebola -- immunology
- Immunity, Mucosal -- drug effects
- Immunotherapy, Active -- methods
- Mice
- Mice, Inbred C57BL
- Polyethylene Glycols -- chemistry
- Survival Analysis
- Virosomes -- immunology
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.